首页 | 本学科首页   官方微博 | 高级检索  
     

长春西汀治疗椎基底动脉供血不足的临床分析
引用本文:全红梅,李光昊,朴成国. 长春西汀治疗椎基底动脉供血不足的临床分析[J]. 中国医药指南, 2013, 0(19): 402-403
作者姓名:全红梅  李光昊  朴成国
作者单位:全红梅 (吉林省延吉市医院 神经内科,吉林 延吉,133000); 李光昊 (吉林省延吉市医院 神经内科,吉林 延吉,133000); 朴成国 (吉林省延吉市医院 神经内科,吉林 延吉,133000);
摘    要:目的观察长春西汀治疗椎基底动脉供血不足临床疗效。方法选择我院2009年7月至2012年7月住院的VBI患者100例,随机分为观察组和对照组各50例。观察组给予长春西汀注射液(河南润弘制药有限公司生产)20mg加入生理盐水或葡萄糖注射液250静滴,1次/d,疗程14天;对照组给予红花黄色素注射液100mg加入生理盐水或葡萄糖注射液250静滴,1次/d,疗程14天。一疗程结束后观察2组临床疗效。结果治疗组总有效率(96%)优于对照组总有效率(84%),两者相比差异有统计学意义(P<0.05)。结论应用长春西汀注射液治疗椎基底动脉供血不足疗效确切,值得临床推广应用。

关 键 词:长春西汀  椎基底动脉供血不足

Vinpocetine Treatment Vertebral Basal Artery Blood Supply Clinical Analysis
QUAN Hong-mei,LI Guang-hao,PIAO Cheng-guo. Vinpocetine Treatment Vertebral Basal Artery Blood Supply Clinical Analysis[J]. Guide of China Medicine, 2013, 0(19): 402-403
Authors:QUAN Hong-mei  LI Guang-hao  PIAO Cheng-guo
Affiliation:(Department of Neurology, Yanji Hospital of Jilin, Yanji 133000, China)
Abstract:Objective Observation vinpocetine treatment vertebral basal artery blood supply clinical curative effect. Methods The 2009-07-2012-07 the hospital 100 cases patients with VBI, Randomly divided into the observation group and the control group of 50 cases each. Observation group was given vinpocetine injection (henan embellish hong pharmaceutical co., LTD., production) 20 mg join physiological saline or glucose injection 250 static drop, a/d, course of 14 days; Control group give carthamin yellow injection 100 mg join physiological saline or glucose injection 250 static drop, a/d, course of 14 days. After a period of treatment to observe clinical efficacy of two groups. Results Treatment group total effective rate (96%) is better than the control group total effective rate (84%), compared to two (P〈0.05). Conclusion Application of vinpocetine injection treatment of vertebral basal artery blood supply exactly curative effect, it is worth clinical application
Keywords:Vinpocetine  Vertebral basal artery blood supply
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号